BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26916537)

  • 1. Prognostic Usefulness of Proenkephalin in Stable Ambulatory Patients With Heart Failure.
    Arbit B; Marston N; Shah K; Lee EL; Aramin H; Clopton P; Maisel AS
    Am J Cardiol; 2016 Apr; 117(8):1310-4. PubMed ID: 26916537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proenkephalin, Renal Dysfunction, and Prognosis in Patients With Acute Heart Failure: A GREAT Network Study.
    Ng LL; Squire IB; Jones DJL; Cao TH; Chan DCS; Sandhu JK; Quinn PA; Davies JE; Struck J; Hartmann O; Bergmann A; Mebazaa A; Gayat E; Arrigo M; Akiyama E; Sabti Z; Lohrmann J; Twerenbold R; Herrmann T; Schumacher C; Kozhuharov N; Mueller C;
    J Am Coll Cardiol; 2017 Jan; 69(1):56-69. PubMed ID: 28057251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proenkephalin and prognosis in heart failure with preserved ejection fraction: a GREAT network study.
    Kanagala P; Squire IB; Jones DJL; Cao TH; Chan DCS; McCann G; Sandhu JK; Quinn PA; McAdam J; Marsh AM; Davies JE; Struck J; Bergmann A; Sabti Z; Twerenbold R; Herrmann T; Kozhuharov N; Mueller C; Ng LL;
    Clin Res Cardiol; 2019 Aug; 108(8):940-949. PubMed ID: 30767059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proenkephalin and prognosis after acute myocardial infarction.
    Ng LL; Sandhu JK; Narayan H; Quinn PA; Squire IB; Davies JE; Bergmann A; Maisel A; Jones DJ
    J Am Coll Cardiol; 2014 Jan; 63(3):280-9. PubMed ID: 24140658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
    Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS
    Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proenkephalin, an Opioid System Surrogate, as a Novel Comprehensive Renal Marker in Heart Failure.
    Emmens JE; Ter Maaten JM; Damman K; van Veldhuisen DJ; de Boer RA; Struck J; Bergmann A; Sama IE; Streng KW; Anker SD; Dickstein K; Lang CC; Metra M; Samani NJ; Ng LL; Voors AA
    Circ Heart Fail; 2019 May; 12(5):e005544. PubMed ID: 31091993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Correlates and Prognostic Value of Proenkephalin in Acute and Chronic Heart Failure.
    Matsue Y; Ter Maaten JM; Struck J; Metra M; O'Connor CM; Ponikowski P; Teerlink JR; Cotter G; Davison B; Cleland JG; Givertz MM; Bloomfield DM; Dittrich HC; van Veldhuisen DJ; van der Meer P; Damman K; Voors AA
    J Card Fail; 2017 Mar; 23(3):231-239. PubMed ID: 27663098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.
    Adlbrecht C; Hülsmann M; Strunk G; Berger R; Mörtl D; Struck J; Morgenthaler NG; Bergmann A; Jakowitsch J; Maurer G; Lang IM; Pacher R
    Eur J Heart Fail; 2009 Apr; 11(4):361-6. PubMed ID: 19190023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome.
    Reardon LC; Williams RJ; Houser LS; Miner PD; Child JS; Aboulhosn JA
    Am J Cardiol; 2012 Nov; 110(10):1523-6. PubMed ID: 22863176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoconcentration is a good prognostic predictor for clinical outcomes in acute heart failure: data from the Korean Heart Failure (KorHF) Registry.
    Oh J; Kang SM; Hong N; Youn JC; Han S; Jeon ES; Cho MC; Kim JJ; Yoo BS; Chae SC; Oh BH; Choi DJ; Lee MM; Ryu KH
    Int J Cardiol; 2013 Oct; 168(5):4739-43. PubMed ID: 23958420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of worsening renal function in outpatients with chronic heart failure.
    Pimentel R; Couto M; Laszczyńska O; Friões F; Bettencourt P; Azevedo A
    Eur J Intern Med; 2014 Sep; 25(7):662-8. PubMed ID: 24986374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of heart failure and adverse cardiovascular events in outpatients with coronary artery disease using mitral E/A ratio in conjunction with e-wave deceleration time: the heart and soul study.
    Mishra RK; Devereux RB; Cohen BE; Whooley MA; Schiller NB
    J Am Soc Echocardiogr; 2011 Oct; 24(10):1134-40. PubMed ID: 21764551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenging the two concepts in determining the appropriate pre-discharge N-terminal pro-brain natriuretic peptide treatment target in acute decompensated heart failure patients: absolute or relative discharge levels?
    Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
    Eur J Heart Fail; 2015 Sep; 17(9):936-44. PubMed ID: 26222618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of ST2 levels with cardiac structure and function and mortality in outpatients.
    Daniels LB; Clopton P; Iqbal N; Tran K; Maisel AS
    Am Heart J; 2010 Oct; 160(4):721-8. PubMed ID: 20934567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32).
    van Hateren KJ; Landman GW; Arnold JF; Joosten H; Groenier KH; Navis GJ; Sparwasser A; Bakker SJ; Bilo HJ; Kleefstra N
    PLoS One; 2015; 10(7):e0133065. PubMed ID: 26218633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
    Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
    Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Von Willebrand factor improves risk prediction in addition to N-terminal pro-B-type natriuretic peptide in patients referred to coronary angiography and signs and symptoms of heart failure and preserved ejection fraction.
    Kleber ME; Koller L; Goliasch G; Sulzgruber P; Scharnagl H; Silbernagel G; Grammer TB; Delgado G; Tomaschitz A; Pilz S; März W; Niessner A
    Circ Heart Fail; 2015 Jan; 8(1):25-32. PubMed ID: 25342739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal function largely influences Galectin-3 prognostic value in heart failure.
    Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
    Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.